Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on September 5, 2025
DIH Holding US, Inc. Receives Nasdaq Staff Determination Letter
GlobeNewswire
·
September 5, 2025
DIH Receives Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market DIH Intends to Request Hearing to Appeal in a Timely Manner NORWELL, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ …
SONORO GOLD ANNOUNCES FURTHER INCREASE IN PRIVATE PLACEMENT
GlobeNewswire
·
September 5, 2025
VANCOUVER, Canada, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) announces that, in response to strong investor demand, it has further increased its fully-subscribed non-brokered …
Crown Castle to Present at the 2025 RBC Capital Markets Global Communications Infrastructure Conference
GlobeNewswire
·
September 5, 2025
HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today that Sunit Patel, Crown Castle’s Executive Vice President and Chief Financial Officer is scheduled to present on Wednesday, September 17, 2025 at 9: …
AI Can Evaluate Social Situations Similar to Humans
EIN Presswire
·
September 5, 2025
Artificial intelligence can detect and interpret social features between people from images and videos almost as reliably as humans. TURKU, FINLAND, September 5, 2025 /EINPresswire.com/ -- Artificial intelligence can detect and interpret social features …
dLocal Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 5, 2025
MONTEVIDEO, Uruguay, Sept. 05, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”), (NASDAQ:DLO) a technology-first payments platform, today announced the closing of a previously announced secondary offering of 17,250,000 Class A common shares (including 2, …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …
Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy
GlobeNewswire
·
September 5, 2025
SAXONBURG, Pa., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, announced today its membership in the Diode Technology Working Group within the STARFIRE Hub, a collaborative initiative led by Lawrence Livermore …
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
GlobeNewswire
·
September 5, 2025
BOSTON and SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …
Artelo Biosciences Announces Closing of $3.0 Million Public Offering
GlobeNewswire
·
September 5, 2025
SOLANA BEACH, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Arvig Launches Digital Life Skills to Boost Digital Literacy, Online Safety for Residents
GlobeNewswire
·
September 5, 2025
PERHAM, Minn., Sept. 05, 2025 (GLOBE NEWSWIRE) -- A high-speed internet connection offers unparalleled opportunities for learning, connection and community impact. Yet, to fully realize its wide-reaching potential, this powerful tool requires one essential …
GPT Proto 2.0 Launches Multi-Model AI Platform with Integrated Content Creation
EIN Presswire
·
September 5, 2025
Revolutionary upgrade transforms API provider into comprehensive AI workspace offering cheaper, faster, and more stable AI solutions LONDON, UNITED KINGDOM, September 5, 2025 /EINPresswire.com/ -- GPT Proto today announced the launch of GPT Proto 2.0, a …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2025 the Company granted inducement awards to …
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
REDWOOD CITY, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum’s Board of Directors granted inducement awards consisting of non-qualified stock options to …
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase …
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 5, 2025
WESTLAKE VILLAGE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today reported the grant of an …
Global Big Data and Analytics Market Valued at $225.3B in 2023, Projected $665.7B by 2033
EIN Presswire
·
September 5, 2025
WILMINGTON, NEW CASTLE, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Big Data and Business Analytics Market by Component (Hardware, Software, and Service), Application (Customer Analytics, …
Environmental Monitoring Market to Reach $43.48 Billion by 2030 | CAGR 8.2%
EIN Presswire
·
September 5, 2025
WILMINGTON, NEW CASTLE, DE, UNITED STATES, September 5, 2025 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global environmental monitoring market generated $19.89 billion in 2020 and is expected to reach $43.48 …
DIAGNOS Announces Closing of Private Placement
GlobeNewswire
·
September 5, 2025
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial …